HWKN vs TROX vs CC vs IOSP

For growth investors, Hawkins, Inc.

(HWKN) is the stronger pick with 6. 0% revenue growth year-over-year, versus -5. 7% for Tronox Holdings plc (TROX). Innospec Inc. (IOSP) offers the better valuation at 17. 2x trailing P/E (16. 2x forward), making it the more compelling value choice. Analysts rate Hawkins, Inc. (HWKN) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Innospec Inc.

(IOSP) is the cheapest at 17. 2x versus Hawkins, Inc. at 41. 5x. On forward P/E, The Chemours Company is actually cheaper at 15. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 51x versus Hawkins, Inc. 's 1. 71x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Hawkins, Inc.

(HWKN) delivered a total return of +409. 1%, compared to -52. 8% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: HWKN returned +766. 7% versus IOSP's +92. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Innospec Inc.

(IOSP) is the lower-risk stock at 0. 71β versus Tronox Holdings plc's 2. 38β — meaning TROX is approximately 235% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hawkins, Inc.

(HWKN) is pulling ahead at 6. 0% versus -5. 7% for Tronox Holdings plc (TROX). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, HWKN leads at 8. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Hawkins, Inc.

(HWKN) is the more profitable company, earning 8. 7% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HWKN leads at 12. 2% versus -0. 7% for TROX. At the gross margin level — before operating expenses — IOSP leads at 27. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 51x versus Hawkins, Inc. 's 1. 71x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Chemours Company (CC) trades at 15. 9x forward P/E versus 42. 4x for Hawkins, Inc. — 26. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 42. 8% to $115. 00.

All stocks in this comparison pay dividends.

Tronox Holdings plc (TROX) offers the highest yield at 3. 4%, versus 0. 4% for Hawkins, Inc. (HWKN).

For long-horizon retirement investors, Innospec Inc.

(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), 2. 1% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 38 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IOSP: +92. 6%, TROX: +123. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HWKN is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock; CC is a small-cap quality compounder stock; IOSP is a small-cap deep-value stock. TROX, CC, IOSP pay a dividend while HWKN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.